Driver mutations in <i>GNAQ</i> and <i>GNA11</i> genes as potential targets for precision immunotherapy in uveal melanoma patients-Reference-Cited by-同舟云学术

Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients

Published:2023-10-24 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

García-Mulero Sandra¹²,Fornelino Roberto¹,Punta Marco³,Lise Stefano³,Varela Mar⁴,del Carpio Luis P.⁵,Moreno Rafael⁵,Costa-García Marcel⁵,Rieder Dietmar⁶,Trajanoski Zlatko⁶,Gros Alena⁷,Alemany Ramón⁵,Piulats Josep María⁸,Sanz-Pamplona Rebeca¹⁹

Affiliation:

1. Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, Barcelona, Spain

2. Anatomy Unit, Department of Pathology and Experimental Therapy, and Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain

3. Bioinformatics Core, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK

4. Department of Pathology, Bellvitge University Hospital, Barcelona, Spain

5. Procure Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain

6. Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria

7. Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

8. Department of Medical Oncology, ICO, IDIBELL and CIBERONC, Barcelona, Spain

9. Institute for Health Research Aragon (IISA), ARAID Foundation, Aragon Government, University Hospital Lozano Blesa, Zaragoza, Spain

Funder

Instituto de Salud Carlos III

Generalitat de Catalunya

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2261278

Reference46 articles.

1. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

2. Treatment of uveal melanoma: where are we now?

3. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

4. Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

5. Uveal melanoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Driver Mutations on Metastasis-Free Survival in Uveal Melanoma: A Meta-Analysis;Cancers;2024-07-10

2. CAR Immunotherapy for the treatment of infectious diseases: a systematic review;Frontiers in Immunology;2024-01-30